Mathew Rose

发表

Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial.

K. Propert, V. Werth, M. Rosenbach, 2014, Journal of the American Academy of Dermatology.

Quality of life in dermatomyositis.

V. Werth, D. Fiorentino, J. Okawa, 2011, Journal of the American Academy of Dermatology.

Cross-sectional analysis of a collaborative Web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients.

V. Werth, M. Costner, J. Okawa, 2009, Archives of dermatology.

Lenalidomide for the treatment of resistant discoid lupus erythematosus.

V. Werth, M. Rosenbach, Asha N. Shah, 2009, Archives of dermatology.

Reliability and convergent validity of two outcome instruments for pemphigus.

A. Troxel, L. Taylor, D. Murrell, 2009, The Journal of investigative dermatology.

A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone

R. Streilein, V. Werth, D. Woodley, 2015, The British journal of dermatology.

Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM.

J. Callen, V. Werth, C. Hansen, 2012, The Journal of investigative dermatology.

The Cutaneous Lupus Erythematosus Disease Activity and Severity Index: expansion for rheumatology and dermatology.

C. Kovarik, A. Troxel, K. Propert, 2008, Arthritis and rheumatism.

Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis

L. Taylor, V. Werth, D. Fiorentino, 2008, The British journal of dermatology.